"Shipments to customers have 'successfully' ramped in the first quarter, he noted, with that development occurring a quarter ahead of when the company was initially expecting."
"As much as happened in the last 12 months in DRAM, we remain excited for what's ahead,"
"With another round of significant price increases coming in Q1 and still indications that supply growth in 2026 will do little to alleviate the intense shortage, we expect further pricing increases through this year,"
"It has since bounced a bit, but investors shouldn't heave a sigh of relief just yet - there is likely more downside ahead, according to Wolfe Research,"
Micron reported HBM4 is in high-volume production and said shipments successfully ramped in the first quarter, a quarter ahead of initial expectations. Shares climbed to $420 and Morgan Stanley raised its price target to $450, citing expected DRAM price increases in Q1 and limited 2026 supply growth that supports further pricing strength. Robinhood shares fell about 9 percent, breaking below prior lows and facing potential downside to $63.50 as Bitcoin weakness and Wolfe Research suggest more downside may be forthcoming. Apple shares declined on reports that the Siri AI launch might be delayed from March to September alongside iOS 27 and the iPhone 18.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]